The National Association of Chain Drug Stores is thanking 37 members of the U.S. House of Representatives who have sent a letter to House and Senate negotiators, urging them to advance an important TRICARE pilot program as part of the FY2017 National Defense Authorization Act.
More than 30 national health care decision-makers have gathered outside of the Nation's Capital this week for an Academy of Managed Care Pharmacy event focusing on innovations in diabetes care that are producing changes to treatment options, patient engagement, accountability and patient-provider interactions.
The National Community Pharmacists Association today announced the establishment of a new Innovation Center that is intended to further assist and speed up the evolution of independent community pharmacies in a changing health care environment.
Avella Specialty Pharmacy has distributed its fifth issue of Dispensing Excellence, a publication for healthcare providers, nurses, medical assistants and their patients.
Elizabeth Holmes, once the world's youngest self-made billionaire, is banned from owning or operating a medical lab for two years.
A new online video announced today by the National Community Pharmacists Association illustrates the personal care that people receive at independent community pharmacies, the contributions of community pharmacists to better coordinated health care and how small business pharmacies support their local communities.
Prepharmacy students may choose to take community college courses to mitigate some expenses and avoid larger student loan debt.
The American Heart Association has released a scientific statement cautioning against the use of some common drugs and supplements in patients with heart failure.
The FDA recently approved lifitegrast ophthalmic solution (Xiidra) to treat both the signs and symptoms of dry eye disease (DED) with an onset of action in as little as 2 weeks.
In recent years, federal agencies have introduced significant regulatory proposals impacting different facets of the pharmaceutical industry.
With the advancing landscape of digital health technology, medication compliance may no longer be a hard pill to swallow.
Mylan has launched a generic version of Merck's Temodar capsules, which may be used to treat patients with newly diagnosed cancerous tumors known as glioblastoma multiforme concomitantly with radiotherapy, then as maintenance treatment.
Although longer needles are often prescribed for patients with increased body fat, this practice actually has no clinical basis.
Check out the top pharmacy headlines from this week.
The FDA has granted Orphan Drug Designation to iBio-CFB03, an investigational biotherapeutic product intended to treat systemic sclerosis.
Although the goals of pharmacogenomics testing are lofty, they have the potential to change pharmacists' practice.
Using a standardized method for taking medication histories is vital to minimizing errors.
Patients benefit when pharmacists thoroughly assess pain.
The American Pharmacists Association Academy of Student Pharmacists, with the support of Amgen, Cardinal Health, and Rite Aid, will host leadership and professional development programming this weekend in Washington, DC, for 240 student pharmacists.
Pharmacists know medications come in many different formulations, but we very rarely recognize that treatment regimens come in various forms, as well.
With new Antimicrobial Stewardship requirements announced for implementation in 2017, Cardinal Health has launched its Antimicrobial Stewardship Program.
This month, the American Pharmacists Association published the fifth edition of the leading textbook on pharmaceutical compounding, The Art, Science, and Technology of Pharmaceutical Compounding.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Frequent CD4 cell monitoring is unnecessary in well-controlled HIV-positive patients, new study results suggest.
The owner of 2 pharmacies in Alabama has agreed to plead guilty to obstructing a Medicare audit.
Patients in Missouri will no longer have to repeat ineffective medications.
The FDA has approved a dedicated syringe for Humulin R U-500 insulin, eliminating the need for dose conversions for patients who previously used U-100 tuberculin syringes.
